Abstract:Small animal fluorescence molecular imaging (FMI) can be a powerful tool for preclinical drug discovery and development studies. However, light absorption by tissue chromophores (e.g., hemoglobin, water, lipids, melanin) typically limits optical signal propagation through thicknesses larger than a few millimeters. Compared to other visible wavelengths, tissue absorption for red and near-infrared (near-IR) light absorption dramatically decreases and non-elastic scattering becomes the dominant light-tissue interaction mechanism. The relatively recent development of fluorescent agents that absorb and emit light in the near-IR range (600-1000 nm), has driven the development of imaging systems and light propagation models that can achieve whole body three-dimensional imaging in small animals. Despite great strides in this area, the ill-posed nature of diffuse fluorescence tomography remains a significant problem for the stability, contrast recovery and spatial resolution of image reconstruction techniques and the optimal approach to FMI in small animals has yet to be agreed on. The majority of research groups have invested in charge-coupled device (CCD)-based systems that provide abundant tissue-sampling but suboptimal sensitivity, while our group and a few others have pursued systems based on very high sensitivity detectors, that at this time allow dense tissue sampling to be achieved only at the cost of low imaging throughput. Here we demonstrate the methodology for applying single-photon detection technology in a fluorescence tomography system to localize a cancerous brain lesion in a mouse model. The fluorescence tomography (FT) system employed single photon counting using photomultiplier tubes (PMT) and information-rich time-domain light detection in a non-contact conformation. This provides a simultaneous collection of transmitted excitation and emission light, and includes automatic fluorescence excitation exposure control, laser referencing, and co-registration with a small animal computed tomography (microCT) system. A nude mouse model was used for imaging. The animal was inoculated orthotopically with a human glioma cell line (U251) in the left cerebral hemisphere and imaged 2 weeks later. The tumor was made to fluoresce by injecting a fluorescent tracer, IRDye 800CW-EGF (LI-COR Biosciences, Lincoln, NE) targeted to epidermal growth factor receptor, a cell membrane protein known to be overexpressed in the U251 tumor line and many other cancers. A second, untargeted fluorescent tracer, Alexa Fluor 647 (Life Technologies, Grand Island, NY) was also injected to account for non-receptor mediated effects on the uptake of the targeted tracers to provide a means of quantifying tracer binding and receptor availability/density. A CT-guided, time-domain algorithm was used to reconstruct the location of both fluorescent tracers (i.e., the location of the tumor) in the mouse brain and their ability to localize the tumor was verified by contrast-enhanced magnetic resonance imaging. Though demonstrated for fluorescence imaging in a glioma mouse model, the methodology presented in this video can be extended to different tumor models in various small animal models potentially up to the size of a rat.

In Vivo Tomographic Imaging of Lung Colonization of Tumour in Mouse with Simultaneous Fluorescence and X‐ray CT

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Full-fieldin Vivoimaging of Nanoparticles Using Benchtop Cone-Beam XFCT System with Pixelated Photon Counting Detector.

In vivo validation of dual-modality system for simultaneous positron emission tomography and optical tomographic imaging

Optical Molecular Imaging-Guided Radiation Therapy Part 2: Integrated X-Ray and Fluorescence Molecular Tomography.

Combined Bioluminescence and Fluorescence Imaging Visualizing Orthotopic Lung Adenocarcinoma Xenograft in Vivo.

In vivo long-term investigation of tumor bearing mKate2 by an in-house fluorescence molecular imaging system

Application of Optical in Vivo Imaging Combined with MRI in Diagnosis of Lung Carcinoma-bearing Mice

Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers

Monitoring of tumor response to cisplatin with simultaneous fluorescence and positron emission tomography: a feasibility study.

A combined fluorescence and microcomputed tomography system for small animal imaging.

Monitoring Of Tumor Response To Cisplatin By Subsurface Fluorescence Molecular Tomography

Dynamic Observation of in Vivo Biofluorescence Imaging in Nude Mouse Model of Human Lung Carcinoma

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

In Vivo Whole-Body Imaging of Optical Agent Dynamics Using Full Angle Fluorescence Diffuse Optical Tomography

Concurrent fluorescence and volumetric optoacoustic tomography of nanoagent perfusion and bio-distribution in solid tumors

A Fast and Automated FMT/XCT Reconstruction Strategy Based on Standardized Imaging Space

Non-invasive visualization of tumors in the mouse liver using a novel nanoparticle contrast enhanced micro-CT imaging procedure

CT- and MRI-Aided Fluorescence Tomography Reconstructions for Biodistribution Analysis

Accurate and Early Metastases diagnosis in live animals with Multimodal X-ray and Optical Imaging

Visualization of GFP-expressing tumors and metastasis in vivo